VACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98026D00086
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN12
Additional Details
The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), has issued an award notice for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract related to vaccine and other biologic manufacturing services for infectious diseases. This procurement, identified by number 75N98026D00086, establishes a guaranteed minimum award of $10,000, signifying the government's commitment to engage the contractor for at least this amount over the contract period.
The primary objective of this contract is to secure specialized manufacturing services that support the development and production of vaccines and other biologic products targeting infectious diseases. The scope encompasses a range of activities within the research and development domain, as classified under NAICS code 541715—Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). This classification indicates a focus on advanced scientific and engineering research, excluding nanotechnology and biotechnology-specific work, but inclusive of broader life sciences applications relevant to infectious disease countermeasures.
The place of performance for this contract is Manassas, Virginia, situating the work within a region known for its robust life sciences and biomanufacturing infrastructure. The Product Service Code (PSC) AN12 further specifies the nature of the services as related to medical research and development, particularly in the area of infectious disease prevention and treatment.
The contracting activity is managed by the NIH NIAID, a federal office under the Department of Health and Human Services. The primary point of contact for this procurement is Hamed Hassanzadeh Makou, who can be reached at [email protected] or by phone at 301-761-7466 for further information or clarification regarding the contract.
This award notice reflects an active procurement status as of July 10, 2026, and is publicly accessible via the SAM.gov portal (Opportunity ID: ceae23c65fbc4397871de268e9a85ae0). While the notice does not specify set-aside requirements or special considerations, the IDIQ structure allows for flexibility in ordering and scaling services as program needs evolve over the contract lifecycle.
Contractors considering this opportunity should note the emphasis on advanced research and manufacturing capabilities in the life sciences, particularly as they pertain to infectious disease solutions. The contract is designed to support the NIH’s mission to advance public health through the development of critical biologic interventions, and successful performance will likely require demonstrated expertise in vaccine and biologic product manufacturing, compliance with federal research standards, and the capacity to respond to evolving public health priorities.
For further details or to assess alignment with your organization’s capabilities, interested parties are encouraged to review the official notice and direct inquiries to the designated NIH contact.